Estudo de coorte | Uso de inibidores da fosfodiesterase 2 está associado a risco aumentado de eventos adversos oculares.

Risk of Ocular Adverse Events Associated With Use of Phosphodiesterase 5 Inhibitors in Men in the US – JAMA Ophthalmology (gratuito por tempo limitado)

Comunicado de imprensa: U.S. insurance claims show strong link between ED medications and vision problems – University of British Columbia

Comentários:

Phase 4 Studies on Phosphodiesterase 5 Inhibitors – JAMA Ophthalmology (gratuito por tempo limitado)

Expert reaction to study looking at risk of vision impairment and loss, and use of phosphodiesterase type 5 inhibitors – Science Media Centre